Magenta Therapeutics Inc
F:3MT
Cash Flow Statement
Cash Flow Statement
Magenta Therapeutics Inc
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(75)
|
(71)
|
(76)
|
|
| Depreciation & Amortization |
2
|
2
|
2
|
|
| Other Non-Cash Items |
10
|
11
|
10
|
|
| Change in Working Capital |
(1)
|
(2)
|
(3)
|
|
| Cash from Operating Activities |
(64)
N/A
|
(60)
+7%
|
(67)
-13%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(0)
|
(1)
|
(0)
|
|
| Other Items |
(10)
|
45
|
(9)
|
|
| Cash from Investing Activities |
(11)
N/A
|
43
N/A
|
(10)
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
68
|
4
|
3
|
|
| Other |
(0)
|
86
|
(0)
|
|
| Cash from Financing Activities |
68
N/A
|
90
+32%
|
3
-97%
|
|
| Change in Cash | ||||
| Net Change in Cash |
(7)
N/A
|
73
N/A
|
(74)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(64)
N/A
|
(61)
+6%
|
(67)
-11%
|
|